Nasdaq Turns Negative on Day, Nasdaq Stocks Selling Off: DCTH, AMED, IMOS, AGNC, MTGE, SRPT

The Nasdaq is turning lower this morning as Apple (NASDAQ:AAPL) weighs it down. AAPL is down about 10% from its over $700 highs in September. Apple isn’t the only Nasdaq stock heading lower today, let’s take a look at six more that are struggling.

Delcath Systems, Inc. (NASDAQ:DCTH) is down 18.18% today at $1.71. DCTH has traded 3.2 million shares so far today, well above its daily average of 1.05 million shares. Delcath said today the FDA has accepted its cancer treatment system for a standard review. Delcath said that the review should be completed within 10 months of submission. The company submitted the application on Aug. 15. The company has a market cap of 111.80 million.

Amedisys Inc. (NASDAQ:AMED) is down 9.98% today at $12.00. AMED has traded 289 thousand shares so far today, above its average of 274 thousand shares. AMED shares are down today after cutting its revenue outlook due to a new contract with Humana. The company has a market cap of 366.11 million.

ChipMOS Technologies LTD. (NASDAQ:IMOS) is down 8.57% today at $12.81. IMOS has traded 280 thousand shares so far today, well above its daily average of 167 thousand shares. The company has a market cap of 352.29 million.

American Capital Agency Corp. (NASDAQ:AGNC) is down 5.28% today at $30.87. AGNC has traded 21.8 million shares so far today, 3 times its daily average. AGNC shares have dropped more than 10% over the past five days and nearly 18% over the past month. American Capital Agency has a market cap of 10.21 billion.

American Capital Mortgage Investment (NASDAQ:MTGE) is down 6.17% this morning at $22.95. MTGE has traded 1.8 million shares so far today, more than double its daily average. MTGE shares have fallen more than 10% over the past week. The company has a market cap of 818.43 million.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is down 2.13% in early trading at $26.47. SRPT has traded 2.9 million shares so far today, 500 thousand shares more than its daily average. SRPT shares have been pulling back recently after the stock shot up from $15 to $45 earlier this month. Sarepta did receive positive comments from Wedbush and Piper Jaffray today on its Duchenne Muscular Dystrophy treatment. The company has a market cap of 594.98 million.

About Kyle Pinder

Kyle Pinder has has over five years trading and research experience in the large cap space. While still in grad school, Kyle trades daily and keep Active Investor up to date with the latest breaking news coming out of Wall Street and Washington.

Speak Your Mind

*

Real Time Web Analytics